tiprankstipranks
Trending News
More News >
Enorama Pharma AB (SE:ERMA)
:ERMA
Sweden Market
Advertisement

Enorama Pharma AB (ERMA) Income Statement

Compare
0 Followers

Enorama Pharma AB Income Statement

Last quarter (Q2 2025), Enorama Pharma AB's total revenue was kr733.00K, a decrease of -87.04% from the same quarter last year. In Q2, Enorama Pharma AB's net income was kr-18.71M. See Enorama Pharma AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
kr 15.77Mkr 1.36Mkr 6.85Mkr 11.04Mkr 2.15M
Gross Profit
kr 3.70Mkr -3.90Mkr -616.00Kkr 2.13Mkr 2.37M
Operating Expenses
kr 51.22Mkr 38.23Mkr 41.35Mkr 29.07Mkr 25.38M
Depreciation and Amortization
kr 20.41Mkr 677.00Kkr 3.54Mkr 663.00Kkr 322.00K
EBITDA
kr -20.41Mkr -43.05Mkr -37.22Mkr -26.28Mkr -22.69M
Operating Income
kr -47.52Mkr -41.84Mkr -41.47Mkr -26.94Mkr -23.01M
Other Income/Expenses
kr 3.71Mkr -2.77Mkr -560.00Kkr -802.00Kkr -445.00K
Pretax Income
kr -43.81Mkr -44.61Mkr -42.03Mkr -27.74Mkr -23.46M
Net Income
kr -43.81Mkr -44.61Mkr -41.78Mkr -28.54Mkr -23.90M
Per Share Metrics
Basic EPS
kr -0.83kr -1.33kr -4.40kr -3.80kr -3.54
Diluted EPS
kr -0.83kr -1.61kr -4.40kr -3.80kr -3.54
Weighted Average Shares Outstanding
53.04M 33.58M 9.49M 7.52M 6.75M
Weighted Average Shares Outstanding (Diluted)
53.04M 27.70M 9.49M 7.52M 6.75M
Currency in SEK

Enorama Pharma AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis